DIVA Laboratories, Ltd. (TPEX:4153)

Market Cap	2.48B
Revenue (ttm)	862.32M
Net Income (ttm)	93.66M
Shares Out	58.67M
EPS (ttm)	1.59
PE Ratio	26.57
Forward PE	n/a
Dividend	2.00 (4.78%)
Ex-Dividend Date	Jun 19, 2024

Volume	13,286
Average Volume	77,115
Open	42.50
Previous Close	42.25
Day's Range	42.10 - 42.50
52-Week Range	31.30 - 55.80
Beta	0.20
RSI	59.77
Earnings Date	May 13, 2025

About DIVA Laboratories

DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial cases; and displays to original design manufacturers (ODM) and original equipment manufacturers (OEMs) customers. It also offers video so...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 154
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4153

Financial Performance

In 2024, DIVA Laboratories's revenue was 862.32 million, a decrease of -3.53% compared to the previous year's 893.84 million. Earnings were 93.66 million, an increase of 27.23%.